Literature DB >> 2492303

Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients.

S K Murthy1, A L Baltch, R P Smith, E K Desjardin, M C Hammer, J V Conroy, P B Michelsen.   

Abstract

This prospective study was designed to determine the incidence of rectal and/or oropharyngeal colonization rates of patients with Pseudomonas aeruginosa upon admission to a general hospital and the risk of becoming colonized while hospitalized. Consecutive 186 admissions (180 patients) to one medical ward, one surgical ward, and the intensive care unit were studied over a period of 5 months. Rectal and oropharyngeal swabs for P. aeruginosa were obtained on admission, weekly thereafter, and/or upon discharge. Forty-two patients (22.6%) were colonized on admission, 20 patients (10.8%) acquired P. aeruginosa during hospitalization. Colonization on admission was observed twice as frequently on the surgical ward and in the intensive care unit as on the medical ward. Positive rectal cultures were more frequent than oropharyngeal cultures throughout the study (P less than 0.01). For patients admitted culture positive or culture negative, the probabilities of remaining culture positive or culture negative, respectively, remained at 44 and 72% after 35 days of hospitalization. The most common P. aeruginosa serotypes were 1, 6, and 10, and pyocin types 1, 3, and 10 were predominant. There was no statistical difference in the serotypes or pyocin types detected on admission or acquired during hospitalization. Except for two hospital-acquired first isolates which were resistant to moxalactam, all first isolates were susceptible to the four antibiotics tested. During the study, one isolate became resistant to azlocillin, gentamicin, and tobramycin, while two isolates became resistant to moxalactam. A statistical analysis was performed for 13 risk factors for all colonized and noncolonized patients. Colonization detected at the time admission was positively associated with age ( > 65 years), previous surgery of the gastrointestinal tract for neoplasm, and anemia ( P< 0.05). In contrast, for patients who entered the study culture negative, none of the analyzed 13 risk factors was associated with an increased probability for colonization. This observation included the administration of antimicrobial agents singly or in combination or both.

Entities:  

Mesh:

Year:  1989        PMID: 2492303      PMCID: PMC267228          DOI: 10.1128/jcm.27.1.35-40.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Improved Culture Methods for the Detection of Ps. pyocyanea.

Authors:  E J Lowbury
Journal:  J Clin Pathol       Date:  1951-02       Impact factor: 3.411

2.  Sources of Pseudomonas aeruginosa infection in burns: study of wound and rectal cultures with phage typing.

Authors:  V L Sutter; V Hurst
Journal:  Ann Surg       Date:  1966-04       Impact factor: 12.969

3.  New immunotype schema for Pseudomonas aeruginosa based on protective antigens.

Authors:  M W Fisher; H B Devlin; F J Gnabasik
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

4.  Epidemiological studies of Pseudomonas species in patients with leukemia.

Authors:  G P Bodey
Journal:  Am J Med Sci       Date:  1970-08       Impact factor: 2.378

5.  Faecal carriage of Pseudomonas aeruginosa by newborn babies.

Authors:  E M Cooke; R A Shooter; S M O'Farrell; D R Martin
Journal:  Lancet       Date:  1970-11-21       Impact factor: 79.321

6.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

Authors:  S C Schimpff; V M Young; W H Greene; G D Vermeulen; M R Moody; P H Wiernik
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

7.  The fate of ingested Pseudomonas aeruginosa in normal persons.

Authors:  A C Buck; E M Cooke
Journal:  J Med Microbiol       Date:  1969-11-04       Impact factor: 2.472

8.  Further studies in the pyocine typing of Pseudomonas pyocyanea.

Authors:  J R Govan; R R Gillies
Journal:  J Med Microbiol       Date:  1969-02       Impact factor: 2.472

9.  Pseudomonas bacteremia. Review of 108 cases.

Authors:  M R Flick; L E Cluff
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

10.  Faecal carriage of Pseudomonas aeruginosa in hospital patients. Possible spread from patient to patient.

Authors:  R A Shooter; K A Walker; V R Williams; G M Horgan; M T Parker; E H Asheshov; J F Bullimore
Journal:  Lancet       Date:  1966-12-17       Impact factor: 79.321

View more
  12 in total

1.  Role of hospital stay and antibiotic use on Pseudomonas aeruginosa gastrointestinal colonization in hospitalized patients.

Authors:  D Lepelletier; N Caroff; D Riochet; P Bizouarn; A Bourdeau; F Le Gallou; E Espaze; A Reynaud; H Richet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

2.  Isolation and characterization of a transposon-induced cytotoxin-deficient mutant of Pseudomonas aeruginosa.

Authors:  L H Bopp; A L Baltch; M C Hammer; M A Franke; R P Smith; F Lutz
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

3.  Antimicrobial susceptibility in gram-negative bacteremia: are nosocomial isolates really more resistant?

Authors:  J E McGowan; E C Hall; P L Parrott
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

4.  Molecular epidemiological study of Pseudomonas aeruginosa isolates from patients with acute leukemia.

Authors:  W Kern; C Wolz; G Döring
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

5.  Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone.

Authors:  Jean-Paul Pirnay; Daniel De Vos; Christel Cochez; Florence Bilocq; Jean Pirson; Marc Struelens; Luc Duinslaeger; Pierre Cornelis; Martin Zizi; Alain Vanderkelen
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

6.  Epidemiological studies of nosocomial infections with Pseudomonas aeruginosa using a DNA probe.

Authors:  A M Joffe; K Volpel; P C Kibsey; W Paranchych
Journal:  Can J Infect Dis       Date:  1992-11

7.  Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit.

Authors:  D C Bergmans; M J Bonten; F H van Tiel; C A Gaillard; S van der Geest; R M Wilting; P W de Leeuw; E E Stobberingh
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

8.  Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.

Authors:  C Peña; A Guzmán; C Suarez; M A Dominguez; F Tubau; M Pujol; F Gudiol; J Ariza
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

9.  Nosocomial outbreak of severe Pseudomonas aeruginosa infections in haematological patients.

Authors:  A Grigis; A Goglio; M Parea; F Gnecchi; B Minetti; T Barbui
Journal:  Eur J Epidemiol       Date:  1993-07       Impact factor: 8.082

10.  Molecular epidemiology of Pseudomonas aeruginosa in an intensive care unit.

Authors:  G Döring; M Hörz; J Ortelt; H Grupp; C Wolz
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.